Overview

Mayo Acute Stroke Trial for Enhancing Recovery

Status:
Completed
Trial end date:
2010-09-01
Target enrollment:
Participant gender:
Summary
This study involves treating patients that have suffered an acute ischemic stroke with the medication donepezil (Aricept ®). The hypothesis is that taking donepezil (FDA-approved for the treatment of Alzheimer's Disease) for the first 90 days following a stroke enhances recovery.
Phase:
Phase 2
Details
Lead Sponsor:
Mayo Clinic
Treatments:
Donepezil